Stem Cell Therapy for Hair Loss: A New Clinical Trial in 2024

Understanding the Problem

Androgenic alopecia, commonly known as male or female pattern baldness, is the most common type of hair loss. It occurs when hair follicles gradually shrink and lose their ability to produce healthy hair. Traditional treatments like minoxidil or finasteride work for some people, but they are not very effective, especially in later stages. Researchers are looking into new ways to stop or even reverse this process.

What are Hair Follicle Stem Cells?

Inside each hair follicle are special cells that manage growth and repair. These mesenchymal stem cells support the follicle. When they weaken or run out, the hair shrinks and eventually stops growing. Scientists questioned whether injecting fresh stem cells from a person’s own healthy follicles could revive thinning areas.

How the Study Was Done

A team in China conducted a clinical trial with 50 men and women aged 25 to 45. They took healthy follicles from the back of each patient’s head, isolated the stem cells, and injected them into balding areas at specific points. To make the results clear, one side of the scalp received the stem cells while the other side received only saline solution as a control. Patients were then observed for nine months to monitor changes.

What the Researchers Found

Improvements appeared quickly. Within one month, the treated areas had more terminal hairs (the thicker, mature strands we want) and a larger hair shaft diameter compared to the untreated side. The benefits lasted for about three months before gradually fading. Importantly, hair that started very thin, under 60 micrometers in diameter, responded best to the therapy. In these cases, the stem cells not only prevented further loss but also helped some follicles thicken.

Safety and Side Effects

Safety was a major focus of the study. Patients experienced only minor temporary reactions, such as slight redness or mild swelling at the injection site, all of which disappeared within a day. No infections or serious complications were reported during the nine months of follow-up. This suggests that using a patient’s own stem cells is a safe approach.

What This Means for Patients

The study indicates that stem cell therapy can make a noticeable difference, especially for people with advanced hair thinning where traditional drugs do little. However, the results were temporary, lasting only a few months. This means that if the treatment becomes available, repeated sessions may be needed to maintain improvements.

Why the 60 Micrometer Threshold Matters

One interesting finding was that hair shaft diameter predicted treatment success. Follicles thinner than 60 micrometers had the most to gain from stem cell injections, while thicker hairs mainly stabilized without much thickening. This could offer doctors a simple way to identify which patients are most likely to benefit from this therapy.

The Bottom Line

Stem cell injections from a person’s own hair follicles present a promising new approach to treating hair loss. While the effects are not permanent and more research is needed to improve the procedure, the results highlight a safe and innovative way to slow or reverse follicle miniaturization. For patients dealing with advanced hair loss, this kind of therapy could soon become an important option alongside existing treatments.

This clinical trial was conducted by researchers at the Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, and was published in the Journal of Cosmetic Dermatology in 2024.

Reference

Gan, Yuyang MD; Du, Lijuan PhD; Wang, Hailin MD; Li, Kaitao PhD; Fan, Zhexiang PhD; Sun, Pingping MD; Zhang, Jiaxian MD; Hu, Zhiqi MD, PhD; Miao, Yong MD, PhD. A Clinical Trial of Treating Androgenic Alopecia with Mesenchymal Stem Cell Suspension Derived from Autologous Hair Follicle. Plastic and Reconstructive Surgery 154(3):p 444e-450e, September 2024. | DOI: 10.1097/PRS.0000000000010841